Intrathecal cdk5 inhibitor, roscovitine, attenuates morphine antinociceptive tolerance in rats

  • Cheng Haung Wang
  • , Tsung Hsing Lee
  • , Yi Jung Tsai
  • , Jong Kang Liu
  • , Yann Jang Chen
  • , Lin Cheng Yang
  • , Cheng Yuan Lu*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

18 Scopus citations

Abstract

AIM: To investigate the effect of cyclin-dependent kinase 5 (Cdk5) inhibitor roscovitine on the morphine antinociceptive tolerance development in rats. METHODS: Tail-flick test as pain threshold measurement and intrathecal injection techniques were used. RESULTS: Intrathecal roscovitine infusion alone produced an antinociceptive effect. Tolerance was induced by continuous intrathecal infusion of morphine 5 μg/h for 5 d. Co-administration of intrathecal roscovitine 1 μg/h for 5 d enhanced the morphine antinociceptive effect in tolerant rats. It also caused a shift in the morphine antinociceptive dose Cresponse curve to the left when co-administered with morphine during tolerance induction, and caused a 67 % reduction in the increase in the ED 50 of morphine (dose producing 50 % of the maximum response). CONCLUSION: Cdk5 modulation is involved in the antinociceptive tolerance of morphine. Intrathecal roscovitine administration could attenuate this tolerance development.

Original languageEnglish
Pages (from-to)1027-1030
Number of pages4
JournalActa Pharmacologica Sinica
Volume25
Issue number8
StatePublished - 08 2004
Externally publishedYes

Keywords

  • Cyclin-dependent kinase 5
  • Morphine
  • Roscovitine

Fingerprint

Dive into the research topics of 'Intrathecal cdk5 inhibitor, roscovitine, attenuates morphine antinociceptive tolerance in rats'. Together they form a unique fingerprint.

Cite this